X0306 4 2020-01-03 false 0001597553 Sage Therapeutics, Inc. SAGE 0001586660 Golumbeski George C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true false false false Stock Options (Right to buy) 73.53 2020-01-03 4 A false 976.00 0.00 A 2030-01-03 Common Stock 976.00 976.00 D The reporting person elected to receive this stock option award in lieu of payment of all cash retainers that would otherwise be paid for his service during 2020 on the issuer's board or its committees, as permitted under the issuer's amended and restated non-employee director compensation policy. The stock option is granted under and subject to the terms of the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. The option will vest in full on December 31, 2020, subject to the reporting person's continued service through such date. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for George Golumbeski 2020-01-07